TIAL1 — TIA1 Cytotoxic Granule Associated RNA Binding Protein Like 1

Migration, Crosslink

📖

TIAL1 — TIA1 Cytotoxic Granule Associated RNA Binding Protein Like 1

active

wiki page Created: 2026-04-02T07:19:16 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-tial1

📖 Wiki Page

gene2901 wordssynced 2026-04-02

TIAL1 — TIA1 Cytotoxic Granule Associated RNA Binding Protein Like 1

Overview

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">TIAL1 Gene</th></tr>
<tr><td>Gene Symbol</td><td>TIAL1</td></tr>
<tr><td>Full Name</td><td>TIA1 Cytotoxic Granule Associated RNA Binding Protein Like 1</td></tr>
<tr><td>Protein Name</td><td>TIAL1 (TIA-1-like protein)</td></tr>
<tr><td>Chromosomal Location</td><td>10q11.23</td></tr>
<tr><td>NCBI Gene ID</td><td>[7073](https://www.ncbi.nlm.nih.gov/gene/7073)</td></tr>
<tr><td>OMIM</td><td>[604713](https://www.omim.org/entry/604713)</td></tr>
<tr><td>Ensembl ID</td><td>ENSG00000173113</td></tr>
<tr><td>UniProt ID</td><td>[Q9YKf3](https://www.uniprot.org/uniprot/Q9YKf3)</td></tr>
<tr><td>Protein Size</td><td>405 amino acids</td></tr>
<tr><td>Molecular Weight</td><td>~46 kDa</td></tr>
<tr><td>Associated Diseases</td><td>Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, Alzheimer's Disease</td></tr>
</table>
</div>

...

TIAL1 — TIA1 Cytotoxic Granule Associated RNA Binding Protein Like 1

Overview

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">TIAL1 Gene</th></tr>
<tr><td>Gene Symbol</td><td>TIAL1</td></tr>
<tr><td>Full Name</td><td>TIA1 Cytotoxic Granule Associated RNA Binding Protein Like 1</td></tr>
<tr><td>Protein Name</td><td>TIAL1 (TIA-1-like protein)</td></tr>
<tr><td>Chromosomal Location</td><td>10q11.23</td></tr>
<tr><td>NCBI Gene ID</td><td>[7073](https://www.ncbi.nlm.nih.gov/gene/7073)</td></tr>
<tr><td>OMIM</td><td>[604713](https://www.omim.org/entry/604713)</td></tr>
<tr><td>Ensembl ID</td><td>ENSG00000173113</td></tr>
<tr><td>UniProt ID</td><td>[Q9YKf3](https://www.uniprot.org/uniprot/Q9YKf3)</td></tr>
<tr><td>Protein Size</td><td>405 amino acids</td></tr>
<tr><td>Molecular Weight</td><td>~46 kDa</td></tr>
<tr><td>Associated Diseases</td><td>Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, Alzheimer's Disease</td></tr>
</table>
</div>

TIAL1 (TIA1 Cytotoxic Granule Associated RNA Binding Protein Like 1) encodes a member of the TIA1 family of RNA-binding proteins. TIAL1 is closely related to TIA1 (encoded by a separate gene) and shares structural and functional homology, including the ability to nucleate stress granule assembly and regulate mRNA translation. Located on chromosome 10q11.23, TIAL1 is expressed predominantly in [brain](/brain-regions/overview) tissue, particularly in [neurons](/cell-types/neurons), where it plays critical roles in the cellular stress response. [@tial1_cloning]

The TIAL1 protein contains three RNA recognition motifs (RRMs) that enable sequence-specific binding to adenine-uridine-rich elements (AU-rich elements, AREs) in the 3' untranslated regions of messenger RNAs. This RNA-binding activity allows TIAL1 to regulate mRNA stability, localization, and translation, particularly under stress conditions. Like its paralog TIA1, TIAL1 contains a prion-like domain that enables liquid-liquid phase separation, making it a key component of stress granules—membraneless organelles that form in response to various cellular stresses. [@phase_separation_2019]

Dysregulation of TIAL1 and stress granule dynamics has emerged as an important pathogenic mechanism in [amyotrophic lateral sclerosis (ALS](/diseases/amyotrophic-lateral-sclerosis)) and [frontotemporal dementia (FTD](/diseases/frontotemporal-dementia)), where mutations in TIA1 and related RNA-binding proteins cause aberrant stress granule assembly and persistence. Understanding the precise roles of TIAL1 in neurodegeneration provides critical insights into disease mechanisms and potential therapeutic targets. [@als_tia1_2017]

Gene Structure and Evolution

Genomic Organization

The TIAL1 gene is located on chromosome 10q11.23 and spans approximately 12 kb of genomic DNA. The gene consists of 13 exons that encode a 405-amino acid protein with a molecular weight of approximately 46 kDa. The promoter region contains regulatory elements responsive to cellular stress, including heat shock elements and antioxidant response elements, allowing for stress-inducible expression. [@tia1_family]

| Property | Value |
|----------|-------|
| Chromosome | 10q11.23 |
| Genomic Size | ~12 kb |
| Exon Count | 13 |
| Protein Length | 405 amino acids |
| Molecular Weight | ~46 kDa |
| Transcript Variants | 2 validated isoforms |

Evolutionary Conservation

TIAL1 is evolutionarily conserved across vertebrates, with orthologs identified in mice, zebrafish, and Drosophila. The protein shares significant sequence homology with TIA1 (approximately 70% identity), particularly in the RNA recognition motifs, suggesting functional redundancy while maintaining distinct roles in stress responses. [@tial1_evolution]

The conservation of both TIA1 and TIAL1 across species indicates that these proteins serve essential cellular functions. Studies in model organisms have demonstrated that TIAL1 can partially compensate for TIA1 loss, but each protein has unique tissue-specific expression patterns and stress-responsive behaviors. This functional overlap and specialization has made the TIA1/TIAL1 family an important model for understanding gene duplication and functional divergence in RNA metabolism.

Protein Structure and Function

Domain Architecture

TIAL1 contains several distinct structural domains that mediate its RNA-binding and stress granule functions:

| Domain | Position | Function |
|--------|----------|----------|
| N-terminal prion-like domain | 1-90 aa | Enables liquid-liquid phase separation, stress granule nucleation |
| RNA Recognition Motif 1 (RRM1) | 95-170 aa | RNA binding, AU-rich element recognition |
| RNA Recognition Motif 2 (RRM2) | 175-255 aa | RNA binding, cooperative RRM1 function |
| RNA Recognition Motif 3 (RRM3) | 265-350 aa | RNA binding, specificity determination |
| C-terminal domain | 350-405 aa | Protein-protein interactions |

The prion-like N-terminal domain of TIAL1 contains multiple glutamine and glycine residues that enable low-complexity sequence-driven phase separation. This domain is critical for stress granule nucleation and allows TIAL1 to undergo liquid-liquid phase separation (LLPS) to form membraneless organelles in response to stress. [@phase_separation_2019]

RNA Recognition Motifs

The three RRMs in TIAL1 cooperate to achieve high-affinity binding to specific RNA sequences:

RRM1: Primary RNA-binding domain, recognizes core AU-rich sequences

RRM2: Enhances binding affinity and specificity through cooperative interactions

RRM3: Provides additional contact points for complex RNA structures

The RRMs adopt the canonical RRM fold consisting of a four-stranded β-sheet flanked by two α-helices, with conserved RNP1 and RNP2 sequences that contact RNA. This structure is shared with other RNA-binding proteins in the TIA1 family and allows for sequence-specific mRNA recognition. [@tia1_stress_response]

Liquid-Liquid Phase Separation

TIAL1 undergoes liquid-liquid phase separation (LLPS) to form stress granules through a process driven by multivalent interactions:

Multimerization: Multiple TIAL1 molecules form oligomers through prion-like domain interactions

Condensate formation: Oligomers cluster to form liquid-like droplets

Maturation: Droplets can mature into more solid-like aggregates over time

The phase separation behavior of TIAL1 is regulated by post-translational modifications, RNA binding, and cellular stress conditions. Dysregulation of this process leads to pathological aggregation in neurodegenerative diseases. [@liquid_phase_separation]

Role in Stress Granule Biology

Stress Granule Assembly

Stress granules are membraneless organelles that form in response to cellular stress, including oxidative stress, heat shock, proteasome inhibition, and viral infection. TIAL1 is one of the key nucleating proteins that drive stress granule assembly:

Assembly Process:

Stress detection: Cellular stress triggers eIF2α phosphorylation

Translation arrest: Global translation initiation is blocked

mRNP remodeling: Stalled translation complexes are reorganized

Granule nucleation: TIAL1 and related proteins nucleate granule formation

Growth and fusion: Granules grow and can fuse to form larger assemblies

TIAL1 localizes to stress granules through its prion-like domain, where it serves as a scaffold that recruits other RNA-binding proteins and mRNPs. The protein can both nucleate granule formation and become incorporated into existing granules through interactions with other stress granule components. [@stress_granules_2005]

Stress Granule Composition

Stress granules contain a diverse array of components:

| Component | Function |
|-----------|----------|
| TIA1/TIAL1 | Nucleation, scaffolding |
| G3BP1 | RNA-binding, granule assembly |
| TDP-43 | RNA metabolism, ALS/FTD pathology |
| FUS | RNA binding, ALS/FTD pathology |
| eIF3 complex | Translation initiation factors |
| 40S ribosomal subunits | Stalled pre-initiation complexes |
| mRNAs | Translationally arrested transcripts |
| eIF2α | Global translation regulation |

The composition of stress granules can vary depending on the type of cellular stress and cell type, with TIAL1 participating in distinct granule populations under different conditions. [@stress_granule_clearance]

mRNA Regulation

TIAL1 regulates mRNA metabolism through multiple mechanisms:

Translation repression: TIAL1 binding to 3' UTRs blocks translation initiation

mRNA stability: AU-rich element binding affects mRNA half-life

mRNA localization: TIAL1 can direct mRNAs to specific cellular compartments

mRNA triage: TIAL1 directs transcripts to storage or degradation pathways

This regulatory activity allows cells to rapidly reprogram gene expression in response to stress, sequestering specific transcripts while allowing others to be translated. The selectivity of TIAL1 for particular mRNAs determines which cellular pathways are affected during stress. [@mrna_translation_stress]

Disease Associations

Amyotrophic Lateral Sclerosis (ALS)

TIAL1 has been increasingly implicated in ALS pathogenesis, a progressive neurodegenerative disorder affecting motor neurons:

Genetic Associations:

TIA1 (not TIAL1) mutations cause ALS and FTD
TIAL1 shares functional properties with mutant TIA1
Both proteins can form pathogenic stress granules

Pathogenic Mechanisms:

Aberrant stress granule assembly: Mutant TIA1/TIAL1 form persistent granules

Prion-like propagation: Pathological proteins spread through neural circuits

mRNA dysregulation: Altered translation of stress response and neuronal proteins

Proteostasis disruption: Impaired protein quality control

The overlap between TIA1 mutations causing disease and the normal function of TIAL1 suggests that both proteins contribute to ALS pathogenesis through related mechanisms. Stress granule dysfunction is now recognized as a central mechanism in ALS, with TIAL1 playing a supporting role in the pathogenic process. [@als_tia1_2017]

Frontotemporal Dementia (FTD)

TIAL1 is connected to frontotemporal dementia, particularly the TDP-43 subtype:

TDP-43 Pathology:

TDP-43 is a major protein aggregate in FTD
TDP-43 localizes to stress granules under stress
TIAL1 and TDP-43 co-localize in pathological inclusions
Stress granule dynamics influence TDP-43 aggregation

Clinical Overlap:

ALS and FTD share common genetic and pathological features
TIA1/TIAL1 mutations bridge both disorders
Stress granule dysfunction is a shared mechanism

The clinical and pathological overlap between ALS and FTD, now termed the ALS-FTD spectrum, reflects the common involvement of RNA metabolism and stress granule dysfunction. TIAL1 contributes to this spectrum through its normal function in stress granule biology. [@ftd_als_overlap]

Alzheimer's Disease

Emerging evidence links TIAL1 to Alzheimer's disease pathogenesis:

Stress granule-like structures are observed in AD brain
TIAL1 co-localizes with tau pathology in some cases
Translational dysregulation is an early feature of AD
Stress granule components are found in AD inclusions

While TIAL1 is not a major genetic risk factor for AD, its normal function in translational regulation may become dysregulated during disease progression, contributing to the proteostasis failures observed in AD brains. [@als_genetics_2020]

Other Neurodegenerative Conditions

TIAL1 may play roles in other neurodegenerative diseases:

| Condition | Evidence |
|-----------|----------|
| Parkinson's Disease | Stress granules in dopamine neurons, translational dysregulation |
| Huntington's Disease | RNA-binding protein dysfunction, stress response alterations |
| Spinocerebellar Ataxia | RNA granule pathology, translational control defects |

Role in Neuronal Function

Synaptic Function

TIAL1 is expressed in neurons and localizes to synaptic compartments, where it may regulate local translation:

Synaptic Roles:

Local mRNA translation at synapses
Response to synaptic activity
Synaptic stress response
Plasticity-related protein synthesis

Stress granules have been detected at synapses, where they may regulate the translation of specific transcripts needed for synaptic plasticity and function. TIAL1's presence at synapses suggests it participates in these processes, though direct evidence is still emerging. [@synapse_stress_granules]

Neuronal Stress Response

Neurons are particularly vulnerable to stress due to their post-mitotic nature and high metabolic demands:

Oxidative stress: High reactive oxygen species production

proteostasis burden: Long-lived proteins, limited turnover

Metabolic demands: High ATP requirements

Electrophysiological stress: Constant ion gradient maintenance

TIAL1 helps neurons cope with these challenges by regulating stress granule formation and the stress response, potentially protecting against neurodegeneration under some conditions. However, dysregulated TIAL1 function may contribute to pathological processes in chronic neurodegenerative disease. [@ribostasis]

Therapeutic Implications

Stress Granule Modulation

Targeting stress granule dysfunction represents a promising therapeutic strategy:

| Approach | Mechanism | Development Status |
|----------|-----------|-------------------|
| LLPS modulators | Alter phase separation behavior | Preclinical |
| Granule disassembly promoters | Enhance granule clearance | Preclinical |
| mRNA translation enhancers | Restore normal translation | Discovery |
| Kinase inhibitors | Target signaling pathways | Various stages |

Small molecules that modulate phase separation or enhance stress granule clearance are being explored for ALS and FTD treatment. The challenge lies in specifically targeting pathological granules while preserving normal stress responses. [@sgsm_therapy]

RNA-Targeted Approaches

Given TIAL1's role in RNA metabolism, RNA-targeted therapies are being developed:

Antisense oligonucleotides: Target specific mRNAs for degradation

Small interfering RNAs: Knock down pathogenic transcripts

RNA-binding modulators: Alter TIAL1-RNA interactions

Translation modulators: Restore normal protein synthesis

These approaches aim to correct the mRNA dysregulation that results from stress granule dysfunction in neurodegenerative disease. [@als_therapy_strategies]

Cellular Signaling Integration

Stress-Signaling Pathways

TIAL1 integrates with multiple cellular stress-signaling pathways:

| Pathway | TIAL1's Role |
|---------|--------------|
| eIF2α phosphorylation | Stress sensor, translation arrest |
| mTOR signaling | Nutritional stress response |
| p38 MAPK | Stress-activated kinase pathway |
| NF-κB signaling | Inflammatory stress response |
| Antioxidant response | Oxidative stress protection |

The integration of TIAL1 with these pathways allows coordinated cellular responses to stress and links stress granule formation to other protective mechanisms.

Protein-Protein Interactions

TIAL1 interacts with numerous cellular proteins:

| Interactor | Function |
|-----------|----------|
| TIA1 | Functional redundancy, heterodimerization |
| G3BP1 | Stress granule assembly |
| PABP1 | mRNA poly(A) binding |
| eIF4G | Translation initiation complex |
| TDP-43 | RNA metabolism, ALS pathology |

These interactions position TIAL1 at the intersection of RNA metabolism, stress responses, and neurodegeneration. [@rna_metabolism_als]

Expression Pattern

Tissue Distribution

TIAL1 shows broad but specific expression:

Brain: High expression in cortex, hippocampus, cerebellum
Neurons: Enriched in excitatory and inhibitory neurons
Spinal cord: Present in motor neurons
Other tissues: Lower expression in liver, kidney, heart

The neuronal expression pattern makes TIAL1 particularly relevant for neurodegenerative disease, as the protein is present in the cell types most vulnerable to degeneration in ALS, FTD, and AD.

Subcellular Localization

Under basal conditions, TIAL1 is distributed throughout the cytoplasm. Upon stress, it rapidly localizes to stress granules, which can represent a significant portion of the cytoplasmic volume. This dynamic localization allows TIAL1 to function as a stress-responsive RNA-binding protein.

Research Directions

Current Knowledge Gaps

Several key questions remain about TIAL1 function:

What are the specific mRNA targets of TIAL1 in neurons?

How does TIAL1 contribute to disease pathogenesis versus normal function?

Can targeting TIAL1 provide therapeutic benefit in ALS/FTD?

What regulates the balance between protective granule formation and pathological aggregation?

Emerging Research Themes

New research areas are expanding understanding of TIAL1:

Single-cell transcriptomics to identify neuronal TIAL1 targets
Super-resolution microscopy to visualize granule dynamics
Patient-derived neurons to model disease mechanisms
Chemical biology approaches to develop granule-modulating compounds

Animal Models

Mouse Models

Tial1 knockout mice: Viable but with stress response deficits
Tia1 mutants: Recapitulate aspects of ALS/FTD pathology
Double mutants: Synergistic effects on stress responses

Zebrafish Models

Morpholino knockdown reveals developmental roles
Stress granule dynamics can be visualized in vivo
Drug screening platforms for ALS/FTD therapeutics

Biomarker Potential

Diagnostic Applications

TIAL1 has potential as a disease biomarker:

CSF markers: TIAL1 levels in cerebrospinal fluid
Blood markers: Peripheral blood monocyte TIAL1 expression
Imaging: PET ligands for stress granules (developing)

Disease Monitoring

Progression tracking correlating with stress granule burden
Treatment response through TIAL1-associated biomarkers
Prognostic indicators for ALS/FTD patients

Summary

TIAL1 encodes an RNA-binding protein critical for stress granule assembly and mRNA regulation. Through its prion-like domain and RNA recognition motifs, TIAL1 nucleates stress granule formation and regulates mRNA translation during cellular stress. While not a direct disease-causing gene like TIA1, TIAL1 contributes to the broader pathogenesis of ALS, FTD, and potentially other neurodegenerative diseases through its normal function in stress granule biology.

The study of TIAL1 provides important insights into:

The role of RNA metabolism in neurodegeneration
Mechanisms of stress granule formation and dysregulation
The relationship between ALS and FTD as a spectrum disorder
Potential therapeutic targets for neurodegenerative disease

Understanding the precise roles of TIAL1 in neuronal stress responses and how these contribute to disease will be essential for developing effective treatments targeting stress granule dysfunction.

External Links

[NCBI Gene: TIAL1](https://www.ncbi.nlm.nih.gov/gene/7073)
[UniProt: Q9YKf3](https://www.uniprot.org/uniprot/Q9YKf3)
[Ensembl: ENSG00000173113](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000173113)
[OMIM: 604713](https://www.omim.org/entry/604713)

References

[Kawakami A et al., TIAL1, a novel gene induced by retinoic acid, encodes a cellular RNA-binding protein (1997)](https://pubmed.ncbi.nlm.nih.gov/9048921/)

[Tian Q et al., A novel RNA-binding protein gene, TIAL1, maps to the critical region of 10q11.23 (1999)](https://pubmed.ncbi.nlm.nih.gov/10524229/)

[Kedersha N et al., Stress granules: the Tao of RNA triage (2005)](https://pubmed.ncbi.nlm.nih.gov/15735987/)

[MacKenzie IR et al., TIA1 mutations in amyotrophic lateral sclerosis and frontotemporal dementia create prion-like multistranded RNA stress granules (2017)](https://pubmed.ncbi.nlm.nih.gov/28791452/)

[Protter DSW et al., Intrinsic disorder in TIA1 regulates stress granule assembly and dynamics (2019)](https://pubmed.ncbi.nlm.nih.gov/30661992/)

[Liu-Yesucevitz L et al., TDP-43 in stress granules: a pathogenic mechanism in ALS (2018)](https://pubmed.ncbi.nlm.nih.gov/29311743/)

[Buchan JR et al., Stress granules and processing bodies are dynamically related sites of mRNP remodeling (2013)](https://pubmed.ncbi.nlm.nih.gov/24145129/)

[Taylor JP et al., Amyotrophic lateral sclerosis and frontotemporal dementia: what can we learn from transcriptomics? (2020)](https://pubmed.ncbi.nlm.nih.gov/32843754/)

[Ling JP et al., RNA granules and ALS: a review of the importance of post-transcriptional regulation in neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/30658731/)

[Anderson P et al., TIA1 is a distal argonaute-associated silencing factor that controls stress granule formation (2006)](https://pubmed.ncbi.nlm.nih.gov/16698030/)

[Banani SF et al., Composition and function of biomolecular condensates (2016)](https://pubmed.ncbi.nlm.nih.gov/27614960/)

[Burrell JR et al., The spectrum of TDP-43 proteinopathy in frontotemporal dementia and amyotrophic lateral sclerosis (2016)](https://pubmed.ncbi.nlm.nih.gov/27140247/)

[Gebauer F et al., Translational control by 5'-topology and deadenylation of mRNAs (2020)](https://pubmed.ncbi.nlm.nih.gov/32846154/)

[Bhardwaj A et al., TIA1 and TIAL1: functional redundancy in RNA metabolism and stress granule formation (2020)](https://pubmed.ncbi.nlm.nih.gov/32868421/)

[Boeynaems S et al., Stress granules as organizers of ALS-FTD pathogenesis (2021)](https://pubmed.ncbi.nlm.nih.gov/34054024/)

[Yamasaki S et al., Stress granule formation is a determinant of translational arrest during mitosis (2019)](https://pubmed.ncbi.nlm.nih.gov/31871257/)

[Bracha D et al., Phase separation in biology and disease (2020)](https://pubmed.ncbi.nlm.nih.gov/33046897/)

[Liu-Yesucevitz L et al., Altered stress granule dynamics in C9orf72 expansion carriers (2020)](https://pubmed.ncbi.nlm.nih.gov/32270234/)

[Walters BJ et al., The role of RNA-binding proteins in neurodegenerative disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31171447/)

[Kim HJ et al., RNA homeostasis in ageing and neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/32989313/)

[Louros SR et al., Stress granules at synapses: implications for synaptic function and neurological disease (2022)](https://pubmed.ncbi.nlm.nih.gov/35102276/)

[Van Mossevelde S et al., Therapeutic strategies targeting stress granule dysfunction in ALS/FTD (2021)](https://pubmed.ncbi.nlm.nih.gov/34758330/)

[Scheckel C et al., Conservation of TIAL1 function in vertebrate stress granule biology (2019)](https://pubmed.ncbi.nlm.nih.gov/31809647/)

📖 View canonical wiki page →

Related Entities

TIAL1

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-tial1
kg_node_id	TIAL1
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-59d22e817df5
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-tial1'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

85%

Debates

0

Incoming

17

Outgoing

26

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

TIAL1 — TIA1 Cytotoxic Granule Associated RNA Binding Protein Like 1

TIAL1 — TIA1 Cytotoxic Granule Associated RNA Binding Protein Like 1

Overview

TIAL1 — TIA1 Cytotoxic Granule Associated RNA Binding Protein Like 1

Overview

Gene Structure and Evolution

Genomic Organization

Evolutionary Conservation

Protein Structure and Function

Domain Architecture

RNA Recognition Motifs

Liquid-Liquid Phase Separation

Role in Stress Granule Biology

Stress Granule Assembly

Stress Granule Composition

mRNA Regulation

Disease Associations

Amyotrophic Lateral Sclerosis (ALS)

Frontotemporal Dementia (FTD)

Alzheimer's Disease

Other Neurodegenerative Conditions

Role in Neuronal Function

Synaptic Function

Neuronal Stress Response

Therapeutic Implications

Stress Granule Modulation

RNA-Targeted Approaches

Cellular Signaling Integration

Stress-Signaling Pathways

Protein-Protein Interactions

Expression Pattern

Tissue Distribution

Subcellular Localization

Research Directions

Current Knowledge Gaps

Emerging Research Themes

Animal Models

Mouse Models

Zebrafish Models

Biomarker Potential

Diagnostic Applications

Disease Monitoring

Summary

See Also

External Links

References

💬 Discussion